EOLS
Companies
NASDAQ
Evolus Inc.
Health Care
$9.30
-$1.74 (-15.76%)
Price Chart
Overview
About EOLS
evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.
Market Cap
$731.9M
Volume
7.2M
Avg. Volume
6.8M
P/E Ratio
51.9
Dividend Yield
0.00%
Employees
267.0
Company Information
Exchange
NASDAQ
Sector
Health Care
Industry
Drug Manufacturers - Specialty & Generic
Website
Risk & Correlation Analysis
Market Correlation
1.10
Moderate Correlation
Volatility
High (0.61)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, EOLS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$731.9M
Volume7.2M
P/E Ratio51.90
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 5, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025